This most recent twist from the Lykos Therapeutics saga threatens A significant overhaul of the organization’s strategy and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to choose to get the business back again towards its nonprofit drug progress roots and a more Doblinite philosophy.A patent application from mental h